Skip to content
Saturday, January 28, 2023
Latest:
  • Oncolytics Biotech® to Host Key Opinion Leader Webinar to Discuss AWARE-1 Data, the Immunotherapeutic Effects of Pelareorep in Breast Cancer, and its Synergistic Activity with CAR T Cells in Solid Tumors
  • Menarini Silicon Biosystems launches CELLSEARCH® Circulating Multiple Myeloma Cells Assay
  • Willow Biosciences Announces Completion of its First Commercial Scale Fermentation Run
  • Eisai Awarded The New Diversity Management Selection 100
  • MindMed Closes Acquisition of HealthMode, a Leading Machine Learning Digital Medicine Company
Biotech Trends Report

Biotech Trends Report

Know First, Act First

  • New Drugs & Trials
  • General
  • Leaders
  • Technology
  • Global
  • Trending

General

BIOTCHNO General 

AbbVie and Eisai Announce an approval for additional indication of HUMIRA

November 27, 2020April 8, 2021 vanessa

AbbVie and Eisai Announce an approval for additional indication of HUMIRA TOKYO, Nov 27, 2020 – (JCN Newswire) – AbbVie

Read more
BIOTCHNO General 

Sierra Oncology Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

November 25, 2020April 14, 2021 vanessa

Canada NewsWire VANCOUVER, BC, Nov. 25, 2020 VANCOUVER, BC, Nov. 25, 2020/CNW/ – Sierra Oncology, Inc. (SRRA), a late-stage biopharmaceutical company

Read more
BIOTCHNO General 

Novo Integrated Sciences, Inc. Engages Investor Acquisition Advisors

November 18, 2020April 8, 2021 vanessa

Novo Integrated Sciences, Inc. Engages Investor Acquisition Advisors  Bellevue, Washington–(Newsfile Corp. – November 18, 2020) –  Novo Integrated Sciences, Inc.

Read more
BIOTCHNO General 

PostEra and NeuroLucent collaborate on identifying small-molecule therapeutics for Alzheimer’s disease

October 25, 2020May 24, 2021 vanessa

Canada NewsWire SAN FRANCISCO and NORTH CHICAGO, Ill., Nov. 25, 2020 SAN FRANCISCO and NORTH CHICAGO, Ill., Nov. 25, 2020/CNW/

Read more
  • Next →

New Drugs & Trials

Mountain Valley MD Files Patent for Novel Vaccine Dose Sparing Adjuvant
BIOTCHNO New Drugs & Trials 

Mountain Valley MD Files Patent for Novel Vaccine Dose Sparing Adjuvant

January 20, 2021April 13, 2021 vanessa

Canada NewsWire MVMD immediately proceeding with selection of Contract Research Organization to conduct adjuvant IPV studyTORONTO,Jan. 20, 2021/CNW/ –Mountain Valley

ImmunoPrecise and Genmab Enter into a Technology Partnership Targeting Infectious Disease
BIOTCHNO New Drugs & Trials 

ImmunoPrecise and Genmab Enter into a Technology Partnership Targeting Infectious Disease

November 19, 2020April 14, 2021 vanessa
Nutra Pharma Provides Updates on Progress of their Nerve Agent Countermeasures
BIOTCHNO New Drugs & Trials 

Nutra Pharma Provides Updates on Progress of their Nerve Agent Countermeasures

November 18, 2020April 8, 2021 vanessa
PostEra enters a multi-year strategic partnership with Pfizer Inc. to advance machine learning for Drug Discovery
BIOTCHNO New Drugs & Trials 

PostEra enters a multi-year strategic partnership with Pfizer Inc. to advance machine learning for Drug Discovery

November 7, 2020April 15, 2021 vanessa
  • Disclaimer
  • Privacy Policy
TD Media LLC dba Life Water Media
1415 South Voss Road Suite 110-431 Houston, TX 77057